Purchase Order 75F40120P00170
Award Date
4/29/20
Potential Completion Date
5/31/21
Potential Value
$112K
Federal Agency
Food and Drug Administration
Awardee
Applikon Biotechnology, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Foster City, CA 94404, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for a BIOREACTOR SYSTEM, which was awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to the prime contractor Eppendorf North America, Inc. The contract has a Firm Fixed Price (FFP) pricing type and a potential value of $198,892.90. The contract was awarded on September 17, 2020 with a completion date of December 16, 2020. The place of performance is Hauppauge, NY 11788, USA. Eppendorf North America, Inc. is a leading...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $981,400 firm fixed price purchase order to Applikon Biotechnology, Inc. to deliver one Applikon Twin LIVIT Flex bioreactor control system. This control system will support the agency's vaccine development programs at its Gaithersburg, Maryland facility, as initially solicited in Amendment #002-Mammalian Bioreactor Control System. The original solicitation sought to procure mammalian bioreactor...
The U.S. Food and Drug Administration (FDA) awarded a $42,455 firm-fixed-price purchase order to Fluigent, Inc., a foreign-owned for-profit organization, for the procurement of microfluidic equipment for organ-on-a-chip studies. This contract, awarded on July 13, 2024, has a completion date of July 14, 2025 and was not set aside for any specific business category. Fluigent, Inc. is a specialized provider of microfluidic solutions, including automated perfusion systems, pressure generators, and...
This is a $140,204.00 firm-fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services' Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of goods. The contract is for the delivery of a Micro-Electrode Assay System, a specialized laboratory instrument used in biomedical research initiatives across agencies like the National Institutes of Health (NIH), EPA, and VA. As a small business set-aside, this award...
The U.S. Department of Health and Human Services Food and Drug Administration (HHS/FDA) awarded a Firm Fixed Price purchase order to Univercells Technologies, a foreign-owned for-profit organization, for the purchase of a Scale-X Carbo Cell Culture Bioreactor System and consumables. The contract, which has a Coronavirus COVID-19 National Interest Action Code, is valued at $245,730.00 and has a completion date of February 15, 2021. The contract was awarded on September 18, 2020 and was not set...
The Food and Drug Administration (FDA) awarded a $465,096.00 firm fixed-price purchase order to Global Life Sciences Solutions USA LLC for the delivery of an XDR-50 single use bioreactor system or equivalent with accessories, training, and installation. The bioreactor system will support the FDA's Center for Drug Evaluation and Research Division of Product Quality Research. The contract has a two-year manufacturer's warranty and a performance period through May 18, 2025. This award was not set...
The Department of Health and Human Services Food and Drug Administration awarded a $149,274.86 firm fixed price purchase order to Eppendorf North America, Inc., a foreign-owned for-profit organization, to purchase DASbox Mini Bioreactor systems or equivalents. The award resulted from a solicitation posted on July 26, 2019, with a due date of August 5, 2019. This contract does not have a set-aside designation. Eppendorf North America is a leading provider of laboratory equipment and services to...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Emulate Inc., a for-profit small business. The contract, valued at $145,260.00, is for the delivery of Emulate's CHIP-S1 Stretchable Chip, a product in their organ-on-a-chip technology line. This technology supports various FDA and HHS initiatives in areas such as personalized medicine, biosurveillance, infectious disease...
This $89,630.00 firm fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration (HHS/FDA) to Univercells Technologies, a foreign-owned, for-profit corporation, to provide UniverCells Bioreactor Consumables. The award was made in response to a pre-solicitation posted by the FDA on June 7, 2021, seeking sources for these bioreactor consumables. The award has an ultimate completion date of November 1, 2021 and was not set aside for any...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Global Life Sciences Solutions USA LLC, a provider of technologies and services that advance the development and manufacture of therapeutics. The $84,557.26 contract is for the provision of an XURI Cell Expansion W25 bioreactor system. This equipment is likely being acquired to support the FDA's biomedical research and laboratory operations. Global Life Sciences Solutions has a history of...